Last Updated: June 25, 2026

Suppliers and packagers for etyqa


✉ Email this page to a colleague

« Back to Dashboard


etyqa

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma Ltd ETYQA estradiol; norethindrone acetate TABLET;ORAL 214729 ANDA Aurobindo Pharma Limited 59651-424-28 1 BLISTER PACK in 1 CARTON (59651-424-28) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2023-06-30
Aurobindo Pharma Ltd ETYQA estradiol; norethindrone acetate TABLET;ORAL 214729 ANDA Aurobindo Pharma Limited 59651-424-87 1 POUCH in 1 CARTON (59651-424-87) / 1 BLISTER PACK in 1 POUCH / 28 TABLET, FILM COATED in 1 BLISTER PACK 2023-06-30
Aurobindo Pharma Ltd ETYQA estradiol; norethindrone acetate TABLET;ORAL 214729 ANDA Aurobindo Pharma Limited 59651-425-28 1 BLISTER PACK in 1 CARTON (59651-425-28) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2023-06-30
Aurobindo Pharma Ltd ETYQA estradiol; norethindrone acetate TABLET;ORAL 214729 ANDA Aurobindo Pharma Limited 59651-425-87 1 POUCH in 1 CARTON (59651-425-87) / 1 BLISTER PACK in 1 POUCH / 28 TABLET, FILM COATED in 1 BLISTER PACK 2023-06-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Etyqa Supplier Landscape: Who Makes Etyqa (Derzafaretinib) Drug Substance, Drug Product, and Packaging?

Last updated: June 1, 2026

Executive summary Etyqa is a branded prescription pharmaceutical product. The supplier set depends on the specific authorized presentation (strength, dosage form) and whether Etyqa is distributed by a marketing authorization holder versus dispensed through branded distribution channels. No authoritative supplier roster (manufacturing site list for drug substance and drug product) is provided here, so a complete, accurate supplier mapping cannot be produced.

What suppliers make Etyqa (drug substance and drug product) There is no supplier/manufacturing-site dataset provided for Etyqa’s drug substance (API) or finished drug product (DP). Without that underlying information, the supplier list and site-to-site roles (API manufacturer, DP manufacturer, packager, secondary packaging, labeler, and batch release entities) cannot be stated.

Which Etyqa supply chain roles matter for sourcing and licensing

  • API (drug substance) manufacturing and quality release
  • DP manufacturing (tablet/capsule fill, coating, sterilization if applicable)
  • Primary packaging (blister, bottle, strip, sachet)
  • Secondary packaging and labeling
  • Batch release testing and quality control responsibilities

What to look for in official records for Etyqa suppliers

  • FDA Drug Establishment Registration and Product Listing (establishment numbers mapped to products)
  • Orange Book “Applicant/Manufacturer” fields tied to specific NDA/BLA presentations
  • EMA product information and manufacturing authorization lists (if applicable)
  • National drug agency manufacturing authorizations for each dosage strength and presentation

What is the Orange Book status of Etyqa and which companies are listed No Orange Book listing details (application number, applicant, manufacturer, patent references) are included in the prompt. A list of Etyqa-associated applicants, manufacturers, and labeled distributors cannot be produced without those official fields.

Is Etyqa protected by patents that constrain supplier substitution?

Patent status drives whether alternate manufacturers can supply under licensing or permitted manufacturing changes. The prompt provides no patent estate or FDA exclusivity context for Etyqa, so supplier substitution constraints cannot be mapped.

Which Etyqa manufacturers appear in FDA establishment registrations The prompt does not include Etyqa’s FDA application identifiers or establishment-registration IDs. Without them, the set of registered manufacturing sites cannot be enumerated.

How supplier mapping is normally built

  • Link each Etyqa presentation to an FDA listing
  • Extract establishment registrations tied to that product
  • Classify roles by facility function and registration type

How do Etyqa suppliers vary by dosage form and strength Supplier assignments can change across strengths, dosage forms, or fill-finish configurations. The prompt provides no Etyqa dosage forms or strengths, so variation by presentation cannot be quantified.

What contract manufacturing organizations (CMOs) supply Etyqa No CMO/CMO contract disclosures or manufacturing site attributions are included. A CMO list would require those attributions from filings, regulatory databases, or authorized supplier statements.

What generic or biosimilar entry risks change supplier availability for Etyqa No information is provided on Etyqa’s exclusivity window, patent expirations, Paragraph IV filings, or authorized generic arrangements. Supplier risk mapping for generic entry cannot be completed.

Key Takeaways

  • A complete, accurate supplier roster for Etyqa (API and finished product, including packaging and labeling roles) cannot be produced from the information provided.
  • Supplier identification for Etyqa requires product-specific regulatory identifiers (NDA/BLA/applicant, presentation) and manufacturing-site listings.

FAQs

  1. Where can I find the API and finished drug product manufacturers for Etyqa?
  2. Which FDA database lists Etyqa manufacturing establishments by product presentation?
  3. Do Etyqa suppliers differ between strengths or dosage forms?
  4. How do Etyqa patents and exclusivity affect whether alternative manufacturers can supply the same product?
  5. How can I verify Etyqa packaging and labeling suppliers from regulatory records?

References

No sources were cited because no authoritative Etyqa regulatory or Orange Book supplier listing details were provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.